ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas

Clinical trial NCT02264613 · COMPLETED

Trial details

NCT number: NCT02264613
Sponsor: Aileron Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Lymphoma Peripheral T-Cell Lymphoma

Start date: 2014-10-01
Primary completion: 2020-03-01
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.